Infante et al. published data demonstrating it is the SPARC in pancreatic cancer stromal fibroblasts that confers a worse prognosis and not the SPARC on pancreatic tumor cells proper [46]. The gene discussed is SPARC; the disease is familial pancreatic carcinoma.